| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Human EPO-alpha (rHu EPO-a) |
|---|
| Description | MW: 21,307 Da. Purity >98% by SDS-PAGE and HPLC analyses. Erythropoietin (EPO), a glycoprotein produced primarily by the kidney, is the principal factor that regulates erythropoiesis by stimulating the proliferation and differentiation of erythroid progenitor cells. The production of EPO by kidney cells is increased in response to hypoxia or anemia. Recombinant EPO has been approved for the treatment of anemia associated with chronic renal failure as well as for anemia of AZT treated AIDS patien |
|---|
| Size | 500 units, 2000 units, 150000 IU |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [human EPO; Human Erythropoietin] |
|---|
| Gene, Accession, CAS # | EPO, Gene ID: 2056, Accession: NP_000790.2 |
|---|
| Catalog # | MBS546211 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human EPO-alpha (rHu EPO-a) from MYBIOSOURCE INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|